Haematologica (Apr 2019)
Phase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasms
- Anna B. Halpern,
- Megan Othus,
- Emily M. Huebner,
- Bart L. Scott,
- Paul C. Hendrie,
- Mary-Elizabeth M. Percival,
- Pamela S. Becker,
- Heather A. Smith,
- Vivian G. Oehler,
- Johnnie J. Orozco,
- Ryan D. Cassaday,
- Kelda M. Gardner,
- Tara L. Chen,
- Sarah A. Buckley,
- Kaysey F. Orlowski,
- Asma Anwar,
- Elihu H. Estey,
- Roland B. Walter
Affiliations
- Anna B. Halpern
- Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington;Department of Medicine, Division of Hematology, University of Washington
- Megan Othus
- Public Health Sciences Division, Fred Hutchinson Cancer Research Center
- Emily M. Huebner
- Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington
- Bart L. Scott
- Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington;Department of Medicine, Division of Medical Oncology, University of Washington
- Paul C. Hendrie
- Department of Medicine, Division of Hematology, University of Washington;Seattle Cancer Care Alliance
- Mary-Elizabeth M. Percival
- Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington;Department of Medicine, Division of Hematology, University of Washington
- Pamela S. Becker
- Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington;Department of Medicine, Division of Hematology, University of Washington
- Heather A. Smith
- Seattle Cancer Care Alliance
- Vivian G. Oehler
- Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington;Department of Medicine, Division of Hematology, University of Washington
- Johnnie J. Orozco
- Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington;Department of Medicine, Division of Hematology, University of Washington
- Ryan D. Cassaday
- Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington;Department of Medicine, Division of Hematology, University of Washington
- Kelda M. Gardner
- Department of Medicine, Division of Hematology, University of Washington
- Tara L. Chen
- Deparment of Pharmacy Services, University of Washington
- Sarah A. Buckley
- Hematology/Oncology Fellowship Program, University of Washington/Fred Hutchinson Cancer Research Center
- Kaysey F. Orlowski
- Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington
- Asma Anwar
- Hematology/Oncology Fellowship Program, University of Washington/Fred Hutchinson Cancer Research Center
- Elihu H. Estey
- Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington;Department of Medicine, Division of Hematology, University of Washington
- Roland B. Walter
- Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington;Department of Medicine, Division of Hematology, University of Washington;Department of Epidemiology, University of Washington, Seattle, WA, USA
- DOI
- https://doi.org/10.3324/haematol.2018.204792
- Journal volume & issue
-
Vol. 104,
no. 4
Abstract
No abstracts available.